Examination of searching about the association between cerebrum, hippocampal atrophy / cerebral ischemic lesion and various atherosclerotic parameters in the chronic kidney disease patient
Not Applicable
Recruiting
- Conditions
- Chronic kidney disease (Stage I-IV)
- Registration Number
- JPRN-UMIN000021180
- Lead Sponsor
- Shonan Kamakura General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
The past history of the stroke or person with the paralysis (aftereffects) Patient in acknowledgment of old infarction or cerebral hemorrhage that was clear by a brain MRI images. The patient who cannot do the examination of cognitive function by visual impairment, a hearing loss or mental instability Patient who cannot secure of intravenous line on the right arms (after operation of breast cancer) Patient with thyroid disease The patient who takes a sleep agent, regularly iodoallergy The patient who have an MRI taboo (e.g. the pacemaker insertion, claustrophobia), a study person will judge to be inappropriate as a study subject
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the cerebrum, the hippocampal atrophy ratio by VSRAD Evaluation of the brain blood flow by the SPECT (123I-IMP)
- Secondary Outcome Measures
Name Time Method An inspection about the item and anamnesis, relations with drugs to reflect an arteriosclerosis-related parameters Difference in brain blood flow, brain atrophy in each CKD stage